Eu Ivdd Eu Ivd General On The Market 🇨🇳 China

MYO Assay Kit CLIA

Devices (same UDI-DI)
1
Certificates
0
Countries
0
Notified Bodies
0

Basic Information

Primary DI
06974521001553
Basic UDI-DI Code
B-06974521001553
Reference
SUPM041036
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
On The Market

Additional Description

This kit is used for in vitro quantitative detection of myoglobin (MYO) in human serum, plasma or whole blood samples. MYO is a kind of protein existing in myocardium and skeletal muscle cytoplasm. It delivers oxygen to muscle cells and can be used as an oxygen storage bag. The molecular weight of MYO is 17.8kD, so it can quickly enter blood circulation after muscle cells are damaged. Determination of MYO in serum is an important marker for diagnosis of acute myocardial infarction (AMI), re-infarction and re-injection diagnosis after thrombolytic therapy. The MYO concentration rises about two hours after symptoms occur, so it can be used as an early index for diagnosis of myocardial infarction.

CND Nomenclature Codes

Code Description
W01021304 MYOGLOBIN

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all